| Autor: |
Saartje Demolder, Veronique Schaevers, Katrien Lagrou, Paul De Munter, Hanne Beeckmans, Geert M. Verleden, Laurent Godinas, Lieven J. Dupont, Pascal Van Bleyenbergh, Natalie Lorent, Robin Vos |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Transplant International, Vol 37 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
1432-2277 |
| DOI: |
10.3389/ti.2024.12061 |
| Popis: |
Lung transplant (LTx) recipients are at high risk for COVID-19 related morbidity and mortality. Data regarding pre-exposure prophylaxis (PrEP) with tixagevimab-cilgavimab in this population are scarce. We therefore evaluated COVID-19 breakthrough infections and COVID-19 related complications after PrEP in a retrospective single-center study, including 264 LTx recipients who received PrEP between June 2022 and December 2022, when Omicron BA.5 was the dominant circulating SARS-CoV-2 variant. PrEP was indicated for fully vaccinated patients with poor seroconversion (anti-S |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
